AMC Entertainment
GameStop
Zomedica
Churchill Capital Corp IV
Ideanomics
Nokia
QuantumScape
Ford Motor
Aphria
Abbott Laboratories (ABT) stock forecast for 2025
The forecast has been updated: November 30, 2023 8:45
Abbott Laboratories stock price online today
Analyst Target Price
121.06Dividend Date
16.02.2021Ex Dividend Date
14.01.2021Last Split Factor
10000:4798Last Split Date
02.01.2013Should you buy or sell Abbott Laboratories stock stock today? What is the projected target price level for 2025? How much will it cost in 2025? Abbott Laboratories stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2025.
We predict the dynamics of the stock market value using resonant artificial intelligence systems.
Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.
Forecasts are adjusted once a day taking into account the price change of the previous day.
To date, analysts have a $121.06 target price for Abbott Laboratories stock stock.
Today 200 Day Moving Average is the resistance level (104.3559 $).
50 Day Moving Average is the resistance level (108.3297 $).
ABT Forecast for 2025
| Month | Rate Forecast | MIN Rate | MAX Rate | Volati- lity, % |
|---|---|---|---|---|
| Jan | 104.93 | 100.98 | 111.64 | 9.55 % |
| Mar | 100.90 | 95.41 | 106.23 | 10.18 % |
| Mar | 102.43 | 97.84 | 104.73 | 6.57 % |
| Apr | 106.28 | 99.57 | 112.75 | 11.69 % |
| May | 109.94 | 107.04 | 112.40 | 4.77 % |
| Jun | 106.60 | 102.16 | 112.74 | 9.38 % |
| Jul | 104.89 | 99.52 | 106.91 | 6.91 % |
| Aug | 103.89 | 101.89 | 108.95 | 6.48 % |
| Sep | 102.72 | 98.61 | 104.45 | 5.59 % |
| Oct | 98.20 | 93.64 | 100.79 | 7.09 % |
| Nov | 101.03 | 96.75 | 106.20 | 8.90 % |
| Dec | 102.89 | 100.17 | 108.24 | 7.45 % |
The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of Abbott Laboratories stock.
Abbott Laboratories overview
Abbott Laboratories Address
100 Abbott Park Road, North Chicago, IL, United States, 60064Market Capitalization
196 439 506 944 $EBITDA
7 823 000 064PE Ratio
58.6118PEG Ratio
3.433Dividend Per Share
1.8Dividend Yield
0.0163EPS
1.891Quarterly Earnings Growth YOY
0.302Quarterly Revenue Growth YOY
0.096Trailing PE
58.6118Forward PE
24.8139EV To Revenue
6.431EV To EBITDA
27.225652 Week High
115.1452 Week Low
60.911450 Day Moving Average
108.3297200 Day Moving Average
104.3559Shares Outstanding
1772359936Shares Float
1758413095Shares Short Prior Month
11849490Short Ratio
1.83Percent Insiders
0.693Percent Institutions
75.579Abbott Laboratories stock forecast for this year
Abbott Laboratories stock forecast for Jan 2025.
Estimated Average Forecasted Abbott Laboratories Price: 104.93. Positive monthly dynamics of the instrument is expected with 9.549% volatility is expected.
Pessimistic forecast: 100.98
Optimistic: 111.64
Abbott Laboratories stock forecast for Mar 2025.
Estimated Average Forecasted Abbott Laboratories Price: 100.90. Negative monthly dynamics of the instrument is expected with 10.182% volatility is expected.
Pessimistic forecast: 95.41
Optimistic: 106.23
Abbott Laboratories stock forecast for Mar 2025.
Estimated Average Forecasted Abbott Laboratories Price: 102.43. Positive monthly dynamics of the instrument is expected with 6.573% volatility is expected.
Pessimistic forecast: 97.84
Optimistic: 104.73
Abbott Laboratories stock forecast for Apr 2025.
Estimated Average Forecasted Abbott Laboratories Price: 106.28. Positive monthly dynamics of the instrument is expected with 11.689% volatility is expected.
Pessimistic forecast: 99.57
Optimistic: 112.75
Abbott Laboratories stock forecast for May 2025.
Estimated Average Forecasted Abbott Laboratories Price: 109.94. Positive monthly dynamics of the instrument is expected with 4.773% volatility is expected.
Pessimistic forecast: 107.04
Optimistic: 112.40
Abbott Laboratories stock forecast for Jun 2025.
Estimated Average Forecasted Abbott Laboratories Price: 106.60. Negative monthly dynamics of the instrument is expected with 9.379% volatility is expected.
Pessimistic forecast: 102.16
Optimistic: 112.74
Abbott Laboratories stock forecast for Jul 2025.
Estimated Average Forecasted Abbott Laboratories Price: 104.89. Negative monthly dynamics of the instrument is expected with 6.907% volatility is expected.
Pessimistic forecast: 99.52
Optimistic: 106.91
Abbott Laboratories stock forecast for Aug 2025.
Estimated Average Forecasted Abbott Laboratories Price: 103.89. Negative monthly dynamics of the instrument is expected with 6.483% volatility is expected.
Pessimistic forecast: 101.89
Optimistic: 108.95
Abbott Laboratories stock forecast for Sep 2025.
Estimated Average Forecasted Abbott Laboratories Price: 102.72. Negative monthly dynamics of the instrument is expected with 5.586% volatility is expected.
Pessimistic forecast: 98.61
Optimistic: 104.45
Abbott Laboratories stock forecast for Oct 2025.
Estimated Average Forecasted Abbott Laboratories Price: 98.20. Negative monthly dynamics of the instrument is expected with 7.093% volatility is expected.
Pessimistic forecast: 93.64
Optimistic: 100.79
Abbott Laboratories stock forecast for Nov 2025.
Estimated Average Forecasted Abbott Laboratories Price: 101.03. Positive monthly dynamics of the instrument is expected with 8.904% volatility is expected.
Pessimistic forecast: 96.75
Optimistic: 106.20
Abbott Laboratories stock forecast for Dec 2025.
Estimated Average Forecasted Abbott Laboratories Price: 102.89. Positive monthly dynamics of the instrument is expected with 7.453% volatility is expected.
Pessimistic forecast: 100.17
Optimistic: 108.24
Other Healthcare sector assets
| Name | Symbol | Last Close Price | Change |
|---|---|---|---|
|
Abbott Laboratories
|
ABT | 95.78 (23.10.2023) | -1.03 % |
 AbbVie Inc.
|
ABBV | 143.41 (01.12.2023) | 0.72 % |
 Aeterna Zentaris Inc.
|
AEZS | 2.87 (14.07.2023) | -1.03 % |
 Allakos Inc.
|
ALLK | 4.65 (14.07.2023) | -2.11 % |
 Allogene Therapeutics, Inc.
|
ALLO | 4.96 (14.07.2023) | -4.89 % |
 Amgen Inc.
|
AMGN | 273.06 (23.10.2023) | -2.06 % |
|
Aphria Inc.
|
APHA | 15.38 (07.05.2021) | 0.00 % |
 Atara Biotherapeutics, Inc.
|
ATRA | 1.83 (14.07.2023) | -8.04 % |
 Aurora Cannabis Inc.
|
ACB | 0.534 (14.07.2023) | -5.94 % |
 Becton Dickinson and Company
|
BDX | 259.39 (14.07.2023) | -0.22 % |
 Biogen Inc.
|
BIIB | 278.4 (17.07.2023) | -0.19 % |
 Biohaven Pharmaceutical Holding Company Ltd.
|
BHVN | 27.37 (20.10.2023) | 1.60 % |
 BioNTech SE
|
BNTX | 92.52 (23.10.2023) | 1.77 % |
 bluebird bio, Inc.
|
BLUE | 3.03 (14.07.2023) | -8.46 % |
 Boston Scientific Corp.
|
BSX | 49.52 (13.10.2023) | 1.81 % |
 Bristol-Myers Squibb Company
|
BMY | 61.85 (17.07.2023) | -0.15 % |
 Canopy Growth Corp.
|
CGC | 0.3841 (14.07.2023) | -40.91 % |
 Castle Biosciences, Inc.
|
CSTL | 12.8 (23.10.2023) | 0.00 % |
|
CLOVER HEALTH INVESTMENTS, CORP
|
CLOV | 3.16 (07.01.2022) | -5.67 % |
 Eli Lilly and Company
|
LLY | 242.27 (04.02.2022) | 0.00 % |
 Emergent BioSolutions Inc.
|
EBS | 7.21 (14.07.2023) | -0.96 % |
 Exelixis, Inc.
|
EXEL | 18.56 (17.06.2022) | 5.63 % |
 G1 Therapeutics, Inc.
|
GTHX | 2.41 (14.07.2023) | -0.82 % |
 Gilead Sciences, Inc.
|
GILD | 77.19 (14.07.2023) | 0.63 % |
 GlaxoSmithKline plc
|
GSK | 34.53 (14.07.2023) | -0.78 % |
 GoodRx Holdings, Inc.
|
GDRX | 7.46 (14.07.2023) | 1.77 % |
 GW Pharmaceuticals plc.
|
GWPH | 218.96 (05.05.2021) | 0.00 % |
 Incyte Corp.
|
INCY | 61.08 (17.07.2023) | -1.10 % |
 Inovio Pharmaceuticals, Inc.
|
INO | 0.5392 (17.07.2023) | 2.70 % |
 Johnson & Johnson
|
JNJ | 166.11 (13.04.2023) | 1.34 % |
 Medtronic plc.
|
MDT | 72.39 (23.10.2023) | -0.43 % |
 Merck & Co., Inc.
|
MRK | 105.57 (17.07.2023) | -1.65 % |
 Moderna, Inc.
|
MRNA | 121.35 (14.07.2023) | -4.15 % |
 Novartis AG
|
NVS | 98.83 (14.07.2023) | 0.51 % |
 Novavax, Inc.
|
NVAX | 8.68 (14.07.2023) | -6.06 % |
 ObsEva SA
|
OBSV | 0.05 (14.07.2023) | 0.00 % |
 OrganiGram Holdings Inc.
|
OGI | 1.49 (17.07.2023) | -4.49 % |
 Pfizer Inc.
|
PFE | 30.84 (23.10.2023) | 0.62 % |
 Regeneron Pharmaceuticals, Inc.
|
REGN | 721.61 (17.07.2023) | 0.43 % |
 Sanofi
|
SNY | 52.68 (14.07.2023) | 1.07 % |
 Schrodinger, Inc.
|
SDGR | 21.99 (23.10.2023) | 0.05 % |
 Senseonics Holdings, Inc.
|
SENS | 0.875 (14.07.2023) | -3.90 % |
 Sorrento Therapeutics, Inc.
|
SRNE | 0.35 (14.07.2023) | -0.28 % |
 Stryker Corp.
|
SYK | 263.57 (23.10.2023) | -0.80 % |
 Sundial Growers Inc.
|
SNDL | 1.42 (17.07.2023) | 1.43 % |
 Teva Pharmaceutical Industries Lim. (TEVA)
|
TEVA | 8.18 (23.10.2023) | 0.74 % |
 Thermo Fisher Scientific Inc.
|
TMO | 461.81 (23.10.2023) | -0.55 % |
 Tilray, Inc.
|
TLRY | 1.69 (17.07.2023) | 1.81 % |
 UnitedHealth Group, Inc.
|
UNH | 527.03 (20.10.2023) | -0.87 % |
 Veeva Systems Inc.
|
VEEV | 178.84 (01.12.2023) | 2.60 % |
|
Zomedica Corp.
|
ZOM | 0.2114 (14.07.2023) | -5.41 % |
 Zynerba Pharmaceuticals, Inc.
|
ZYNE | 1.3 (11.10.2023) | 0.00 % |
Warning: include(include/reklama_bottom.php): failed to open stream: No such file or directory in /home/virtwww/w_leoprophet-com_a7e4ac46/http/wp-content/themes/generatepress/forecast_stock_post_year.php on line 808 Warning: include(): Failed opening 'include/reklama_bottom.php' for inclusion (include_path='.:') in /home/virtwww/w_leoprophet-com_a7e4ac46/http/wp-content/themes/generatepress/forecast_stock_post_year.php on line 808
Denial of responsibility:
The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.